Author

K. Mansfield

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 2 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Assay:DNA methylation· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Newell· 1 shared A. Romeike· 1 shared A.-K. Haverkamp· 1 shared C. McElroy· 1 shared D. Cunha· 1 shared D. H. O'Connor· 1 shared D. Rancour· 1 shared E. Hudry· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Newell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A NEW VARIANT OF HEPATITIS A VIRUS CAUSING TRANSIENT LIVER ENZYME ELEVATIONS IN MAURITIUS-ORIGIN LABORATORY-HOUSED CYNOMOLGUS MACAQUES

L. Mecklenburg, R. Ducore, M. Boyle, A. Newell, L. Boone, J. Luft, A. Romeike, A.-K. Haverkamp, K. Mansfield, J. Baczenas, N. Minor, S. L. O'Connor, D. H. O'Connor

A new HAV genotype causing transient liver enzyme elevations in macaques was identified using deep sequencing, and vaccination prevented recurrence.

bioRxiv · Nov 18, 2022 · PreprintMicrobiology

Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques

E. K. Meseck, G. Guibinga, S. Wang, C. McElroy, E. Hudry, K. Mansfield

This study evaluates the biodistribution of scAAV9-CB-GFP in cynomolgus macaques after intrathecal administration, showing systemic spread and limited brain neuronal transduction.

bioRxiv · Nov 28, 2021Pharmacology & Toxicology

A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.

G. Baisa, D. Rancour, K. Mansfield, M. Burns, L. Martin, D. Cunha, J. Fischer, F. Muecksch, T. Hatziioannou, P. Bieniasz, F. Schomburg, K. Luke

This study evaluates a recombinant SARS-CoV-2 vaccine in macaques, showing that antigens from the RBD elicit high-titer neutralizing antibodies lasting over 20 weeks.

bioRxiv · Dec 20, 2020 · PreprintImmunology